About News News Subscribe Economics Health Policy Facet Area of Focus - News Ian H. Solomon Craig Volden Brian N. Williams Christine Mahoney Gerald Warburg Jay Shimshack Kirsten Gelsdorf Philip Potter Benjamin Castleman David Leblang Gabrielle Adams Lucy Bassett John Holbein Daphna Bassok Allan Stam Andrew S. Pennock Raymond C. Scheppach Sophie Trawalter Timothy L. Davis Bala Mulloth Jeanine Braithwaite Jill Rockwell Sebastian Tello-Trillo Paul S. Martin Sarah Turner Steve Hiss Todd S. Sechser Benjamin Converse James H. Wyckoff Jennifer Lawless Laura Toscano Michael D. Williams Noah Myung Peter Johannessen Brooke Lehmann Harry Harding Jeff Chidester Margaret Foster Riley Molly Lipscomb William Shobe Adam Leive Brad Carson Daniel W. Player Eileen Chou Frederick P. Hitz Galen Fountain Isaac Mbiti Jazmin Brown-Iannuzzi Larry Terry Michele Claibourn Sally Hudson Adam Roux Allison Atteberry Amanda Crombie Andy Ortiz Brendan J. Boler Brooke Ray Charles J. Rush Charles J. Rush Derek Wu Diane Biesecker George Foresman Jieun Pai Justin H. Kirkland Kimberly Jenkins Robinson Melissa Thomas-Hunt Michele Claibourn Pam Cipriano Paul Becker (-) Christopher J. Ruhm Facet People - News Facet UVA Partner - News Research and Commentary Facet News Type - News Jun 23, 2022 We May Not Have Been as Anxious, Depressed in Pandemic's First Year as Once Thought Health Policy Findings from the Batten School's Christopher Ruhm and colleagues at Harvard question the accuracy of the CDC’s Household Pulse survey on mental health. Learn more May 17, 2021 How to target opioid funding to states that need it most Health Policy Economics According to new research from Batten’s Christopher J. Ruhm, the federal government’s opioid grant funding structure favors the least populous states, which are not always the states with greatest need. In an op-ed for The Hill, Ruhm suggests several ways to improve the targeting of federal grants that aim to assist states with opioid problems. Read in The Hill May 03, 2021 Federal Opioid Grant Funding Favors Least Populous States, Not Those With the Greatest Need Economics Health Policy In a new paper published in the journal Health Affairs, Batten’s Christopher J. Ruhm and co-author Bradley A. Katcher find that the federal government’s opioid grant funding structure favors the least populous states, which are not always the states with greatest need. Learn more Apr 09, 2020 How Might the COVID-19 Recession Affect Your Health? An Economist Explains. Economics Health Policy Recessions may be good for overall physical health, but this one could be different. Batten professor Chris Ruhm presented an online talk Wednesday offering an economist’s view of the overall health effects of the COVID-19 recession. His talk was the school’s third installment of its expert chat series about COVID-19. Learn more Nov 21, 2019 New Research: Non-Opioid Drug Death Rates Are Also on the Rise Economics The number of Americans dying from drug overdoses has risen rapidly in the last decade, with opioids viewed as the primary culprit. However, recent research suggests that opioids are not the only drug involved. According to Batten professor of economics, Christopher J. Ruhm, half of the overdose deaths have involved polydrug use and deaths involving nonopioid drugs are rising almost as fast as those involving opioids. READ IN UVA TODAY Stay Up To Date with the Latest Batten News and Events Subscribe
Jun 23, 2022 We May Not Have Been as Anxious, Depressed in Pandemic's First Year as Once Thought Health Policy Findings from the Batten School's Christopher Ruhm and colleagues at Harvard question the accuracy of the CDC’s Household Pulse survey on mental health. Learn more
May 17, 2021 How to target opioid funding to states that need it most Health Policy Economics According to new research from Batten’s Christopher J. Ruhm, the federal government’s opioid grant funding structure favors the least populous states, which are not always the states with greatest need. In an op-ed for The Hill, Ruhm suggests several ways to improve the targeting of federal grants that aim to assist states with opioid problems. Read in The Hill
May 03, 2021 Federal Opioid Grant Funding Favors Least Populous States, Not Those With the Greatest Need Economics Health Policy In a new paper published in the journal Health Affairs, Batten’s Christopher J. Ruhm and co-author Bradley A. Katcher find that the federal government’s opioid grant funding structure favors the least populous states, which are not always the states with greatest need. Learn more
Apr 09, 2020 How Might the COVID-19 Recession Affect Your Health? An Economist Explains. Economics Health Policy Recessions may be good for overall physical health, but this one could be different. Batten professor Chris Ruhm presented an online talk Wednesday offering an economist’s view of the overall health effects of the COVID-19 recession. His talk was the school’s third installment of its expert chat series about COVID-19. Learn more
Nov 21, 2019 New Research: Non-Opioid Drug Death Rates Are Also on the Rise Economics The number of Americans dying from drug overdoses has risen rapidly in the last decade, with opioids viewed as the primary culprit. However, recent research suggests that opioids are not the only drug involved. According to Batten professor of economics, Christopher J. Ruhm, half of the overdose deaths have involved polydrug use and deaths involving nonopioid drugs are rising almost as fast as those involving opioids. READ IN UVA TODAY